advocacy

Politics Nicholas Florko

STAT Plus: Tanden, Becerra, Califf make time for a meeting with tobacco lobbyists on the menthol ban

Pharmalot Ed Silverman

STAT Plus: Vertex pushes a donation program to widen access to cystic fibrosis treatments, but advocates say it’s not enough

First Opinion Phyllis Vine

What Rosalynn Carter understood about mental health

First Opinion Emily Freeman

Ohio has enshrined the right to an abortion. But major obstacles remain for patients and providers

First Opinion Robert Kadlec, Sue Anne Bell, and Michael Wasserman

Congress must reauthorize the National Advisory Committee for Seniors and Disasters

D.C. Diagnosis Rachel Cohrs

Medicare eligibility is tripping up the GOP presidential candidates

First Opinion Jennifer Canvasser

Pulling probiotics from NICUs can put preemies at risk of necrotizing enterocolitis

First Opinion Podcast Torie Bosch

Listen: Putting an end to a racist ‘diagnosis’

First Opinion Elsa Pearson Sites

Many Americans receive too much health care. That may finally be changing

First Opinion Alexandra Plante

There’s a real risk that harm reduction could be a fad

First Opinion Ed Bisch

I lost my son to OxyContin. ‘The Fall of the House of Usher’ is my Sackler revenge fantasy

First Opinion Vivian Kobusingye Birchall

The pink ribbon of breast cancer awareness needs a splash of blue for men

First Opinion David Panzirer

Insulin is increasingly affordable in the U.S. What about the rest of the world?

Pharmalot Ed Silverman

STAT Plus: Court strikes down Trump-era rule that allowed health insurers to broadly use copay accumulators

Pharmalot Ed Silverman

STAT Plus: J&J agrees not to enforce patents on a key tuberculosis drug in dozens of poor countries

Politics Sarah Owermohle

STAT Plus: With Menendez indictment, pharmaceutical industry could lose a key ally

Health Nicholas Florko

Dairy farmers are running out of chances to kill the terms ‘oat milk’ and ‘soy milk’

First Opinion Kristina Bohdanova, Marina Weiss, and Samantha Weckesser

Lessons from Ukraine on protecting mental health during conflict

First Opinion Alison Block

Brain drain, skills loss, and other unintended consequences of overturning Roe v. Wade

Politics John Wilkerson

STAT Plus: PBMs were the target of House hearing, but pharma wasn’t spared criticism

Politics Rachel Cohrs

STAT Plus: Chamber of Commerce, government clash at first court hearing on Medicare drug prices

First Opinion Mical Raz and Naftali Kaminski

Doctors in the U.S. can learn a lot about advocacy and activism from their Israeli counterparts

First Opinion Abdullahi Tsanni

I saw firsthand in Nigeria that drugs alone can’t win the war against tuberculosis

Politics Rachel Cohrs

STAT Plus: Pharma industry showers House GOP doctor with campaign cash

Politics Nicholas Florko

STAT Plus: Cannabis industry scales back its lobbying in Washington

Politics Rachel Cohrs

STAT Plus: Lobbying spending dropped for companies that departed PhRMA

Politics Rachel Cohrs

STAT Plus: Conservative group opposing PBM reform spends record number on lobbying

Exclusive Rachel Cohrs

STAT Plus: Key House panel plots a new health care package — complicating the chamber’s agenda

Politics John Wilkerson

STAT Plus: Protesters slam health insurance lobby for Medicare Advantage coverage restrictions